Quellen:

 (1) Plumb D.C.:

   Veterinary Drug Handbook

   PharmaVet Publishing, White Bear Lake (USA); 853 pp, 1999

 (2) Riviere JE & Spoo JW:

   Tetracycline Antibiotics.
   In: Veterinary Pharmacology and Therapeutics

   (HR Adams, ed), Iowa State University Press, Ames (USA) 7: pp 784-796, 1995

 (3) Wilson RC, Kemp DT, Kitzman JV & Goetsch DD:

   Pharmacokinetics of doxycycline in dogs.

   Can J Vet Res 52(1): 12-14, 1988

 (4) Bousquet E, Moran H, Aitken I. and Morgan HJ.

   Comparative in vitro activitiy of doxycycline and oxytetracycline
   against porcine respiratory pathogens.

   Vet. Rec. 141, pp. 37 – 40, 1997

 (5) Gicquel M., Sanders P., Laurentie M. and Bousquet E.

   Pharmacodynamic activity of doxycycline against Actinobacillus
   pleuropneumoniae and Bordetella bronchiseptica strains isolated
   from pneumonic pigs.

   Proc. 15th IPVS Congress, Birmingham, 1998, 276.

 (6) Barza M., Brown R.B., Shanks C., Gamble C. and Weinstein L.

   Relation between lipophilicity and pharmacological behavior of
   minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

   Antimicrob. Agents Chemother. 1975, 8, 713-720.

 (7) Gutierrez C.B., Piriz S., Vadillo S. and Rodriguez Ferri E.F.

   In vitro susceptibility of Actinobacillus pleuropneumoniae strains to
   42 antimicrobial agents.

   Am. J. Vet. Res. 1993, 54, 546-550.

 (8) Aronson A.L.

   Pharmacotherapeutics of the newer tetracyclines.

   J. Am. Vet. Med. Assoc. 1980, 176, 1061-1068.

 (9) Bousquet E, Nouws J, Terlouw P & De Kleyne S:

   Pharmacokinetics of doxycycline in pigs following oral administration
   in feed.

   Vet Res 29(5): 475-485, 1998

(10) Bousquet E, Pommier P, Wessel-Robert S, Morvan H,
       Benoit-Valiergue H & Laval A:

   Efficacy of doxycycline in feed for the control of pneumonia caused by
   Pasteurella multocida and Mycoplasma hyopneumoniae in fattening pigs.

   Vet Rec 143(10): 269-272, 1998

(11) Kroker R:

   Pharmaka zur Behandlung und Verhütung bakterieller Infektionen
   In: Pharmakotherapie bei Haus- und Nutztieren

   (W Löscher, FR Ungemach & R Kroker, eds), Parey, Berlin (D); pp 211-246, 1999

(12) Riond JL & Riviere JE:

   Pharmacology and Toxicology of Doxycycline.

   Vet Hum Toxicol 30: 431, 1988

(13) Barza M., Brown R.B., Shanks C., Gamble C. and Weinstein L.

   Relation between lipophilicity and pharmacological behavior of
   minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

   Antimicrob. Agents Chemother. 1975, 8, 713-720.

(14)Forth W.

   Allgemeine und spezielle Pharmakologie und Toxikologie.

   Spektrum Akademischer Verlag, Heidelberg; 716 pp, 1996

(15) Ose E.E.

  In vitro antibacterial properties of EL-870, a new
  semisynthetic macrolide antibiotic.

  J. Antibiotics, 40 (2): 190-194, 1987

(16) Ter Laak E.A., Pijpers A., Noordergraaf J.H.,
       Schoevers E.C. and Verheijden J.H.:

   Comparision of methods for in vitro testing of susceptibility of
   porcine Mycoplasma species to antimicrobial agents.

   Antmicrob. Agents and Chemother; 35; 228 - 233; 1991